"Luminal breast cancer" trang 1 - tải miễn phí từ tailieuXANH
Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
16    56    0
Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing

Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing
12    51    0
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
10    74    0
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
10    52    0
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
13    57    0
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
7    44    0
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: Results from a prospective randomised trial

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: Results from a prospective randomised trial
10    64    0
Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial
9    169    1
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer

Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
17    52    1
Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment

Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment
12    59    0
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
17    58    0
Active behavior of triple-negative breast cancer with adipose tissue invasion: A single center and retrospective review

Active behavior of triple-negative breast cancer with adipose tissue invasion: A single center and retrospective review
11    57    1
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
8    41    0
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    55    0
Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer

Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer
10    75    0
Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: A multicenter analysis

Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: A multicenter analysis
8    56    0
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
13    91    0
IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells

IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
11    68    0
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
10    72    0
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
8    54    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.